Funder
the General Program (Major Research Plan) of National Natural Science Foundation of China
the National Key Research and Development Program of China
the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference37 articles.
1. Al-Dhamin Z, Liu L, Li D, Zhang S, Dong S, Nan Y (2020) Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: a systematic review of studies. World J Gastroenterol 26(47):7444–7469. https://doi.org/10.3748/wjg.v26.i47.7444
2. Arias M, Lahme B, Van de Leur E, Gressner AM, Weiskirchen R (2002) Adenoviral delivery of an antisense RNA complementary to the 3’ coding sequence of transforming growth factor-β1 inhibits fibrogenic activities of hepatic stellate cells. Cell Growth Differ 13(6):265–273
3. Ashrafizadeh M, Najafi M, Orouei S, Zabolian A, Saleki H, Azami N, Sharifi N, Hushmandi K, Zarrabi A, Ahn K (2020a) Resveratrol modulates transforming growth factor-beta (TGF-β) signaling pathway for disease therapy: a new insight into its pharmacological activities. Biomedicines 8(8):261. https://doi.org/10.3390/biomedicines8080261
4. Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam E, Hashemi F, Makvandi P, Samarghandian S, Khan H, Hashemi F, Najafi M, Mirzaei H (2020b) Toward regulatory effects of curcumin on transforming growth factor-beta across different diseases: a review. Front Pharmacol 11:585413. https://doi.org/10.3389/fphar.2020.585413
5. Böttcher K, Pinzani M (2017) Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv Drug Deliv Rev 121:3–8. https://doi.org/10.1016/j.addr.2017.05.016
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献